Laman UtamaI9DN • FRA
add
Arbutus Biopharma Corp
Tutup sebelumnya
€2.86
Julat hari
€2.92 - €2.92
Julat tahun
€2.45 - €4.22
Permodalan pasaran
679.75J USD
Bilangan Purata
259.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 1.57J | -26.62% |
Perbelanjaan pengendalian | 8.43J | 65.30% |
Pendapatan bersih | -12.53J | 35.11% |
Margin untung bersih | -796.19 | 11.57% |
Pendapatan bagi setiap syer | -0.10 | 38.71% |
EBITDA | -15.34J | 23.94% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 122.62J | -2.68% |
Jumlah aset | 131.71J | -8.79% |
Jumlah liabiliti | 34.34J | -10.53% |
Jumlah ekuiti | 97.37J | — |
Syer tertunggak | 191.48J | — |
Harga kepada buku | 5.61 | — |
Pulangan pada aset | -28.79% | — |
Pulangan pada modal | -36.08% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -12.53J | 35.11% |
Tunai daripada operasi | -10.32J | 40.35% |
Tunai daripada pelaburan | 13.41J | -39.66% |
Tunai daripada pembiayaan | 1.42J | -62.67% |
Perubahan bersih dalam tunai | 4.48J | -48.78% |
Aliran tunai bebas | -10.96J | -18.93% |
Perihal
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Diasaskan
2007
Tapak web
Pekerja
44
